EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent
Presenter:
New at TCTMD? Register today!
Enter the email you used to register to reset your password.